A detailed history of Global Financial Private Client, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Global Financial Private Client, LLC holds 69 shares of CTLT stock, worth $4,207. This represents 0.0% of its overall portfolio holdings.

Number of Shares
69
Previous 69 -0.0%
Holding current value
$4,207
Previous $3.88 Million 7.71%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

May 15, 2024

BUY
$47.06 - $56.64 $3,247 - $3,908
69 New
69 $3.89 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Global Financial Private Client, LLC Portfolio

Follow Global Financial Private Client, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Financial Private Client, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Financial Private Client, LLC with notifications on news.